Transforming potential of the c-fms proto-oncogene (CSF-1 receptor)

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Nature

• Publication date

  1987-02-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/325549A0PMID 3027579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies to distal carboxyl terminal epitopes in the v-fms-coded glycoprotein do not cross-react with the c-fms gene product.

  1986cited by this paper
• The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line

  1986cited by this paper
• Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus

  1986cited by this paper
• Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines.

  1986cited by this paper
• The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences

  1986cited by this paper
• Activation of the transforming potential of p60c-src by a single amino acid change.

  1986cited by this paper
• Tyr527 is phosphorylated in pp60c-src: implications for regulation.

  1986cited by this paper
• Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene.

  1986cited by this paper
• The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

  1985cited by this paper
• Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src

  1985cited by this paper
• Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1).

  1985cited by this paper
• Activation of the pp60c‐src kinase by middle T antigen binding or by dephosphorylation.

  1985cited by this paper
• Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts.

  1984cited by this paper
• Construction and applications of a highly transmissible murine retrovirus shuttle vector.

  1984cited by this paper
• Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-specific protein kinases.

  1984cited by this paper
• Autophosphorylation sites on the epidermal growth factor receptor

  1984cited by this paper
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

  1984cited by this paper
• Cell surface expression of v-fms-coded glycoproteins is required for transformation

  1984cited by this paper
• Subcellular localization of glycoproteins encoded by the viral oncogene v-fms

  1984cited by this paper
• Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases.

  1984cited by this paper
• Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus.

  1983cited by this paper
• Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor.

  1983cited by this paper
• Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus

  1983cited by this paper
• McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms)

  1982cited by this paper
• Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

  1982cited by this paper

• Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor.

  2025cites this paper
• Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpression

  2025cites this paper
• MicroRNA-34 and gastrointestinal cancers: a player with big functions

  2024cites this paper
• Systematic Assessment of Protein C-Termini Mutated in Human Disorders

  2023cites this paper
• Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease

  2022cites this paper
• Events Occurring in the Axotomized Facial Nucleus

  2022cites this paper
• Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages

  2021cites this paper
• Discovery of IACS-9439, a potent, exquisitely selective and orally bioavailable inhibitor of CSF1R.

  2020cites this paper
• PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma.

  2020cites this paper
• Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer

  2020cites this paper
• Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin

  2016cites this paper
• The PDGFR Receptor Family

  2015cites this paper
• Development of antibodies against the canine CSF-1R

  2015cites this paper
• Receptor Tyrosine Kinases: Family and Subfamilies

  2015cites this paper
• Recently targeted kinases and their inhibitors-the path to clinical trials.

  2014cites this paper
• Novel thiazole derivatives: a patent review (2008 – 2012; Part 1)

  2014cites this paper
• Receptor-type protein tyrosine phosphatase zeta is a functional receptor for interleukin-34*

  2013cites this paper
• Receptor-type Protein-tyrosine Phosphatase ζ Is a Functional Receptor for Interleukin-34*

  2013cites this paper
• Localization of CSF-1 Receptor intracellular domain in the nucleus after its release from the plasma membrane by regulated intramembrane proteolysis

  2012cites this paper
• Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation

  2012cites this paper
• CSF-1R up-regulation is associated with response to pharmacotherapy targeting tyrosine kinase activity in AML cell lines.

  2012cites this paper
• macrophages stimulated by colony-stimulating factor 1 Cloning and expression of murine interleukin-1 receptor antagonist in

  2011cites this paper
• CSF1R (colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog)

  2011cites this paper
• cells and M-CSF receptor-bearing hematopoietic cells (M- CSF) to its receptor mediates specific adhesion between stromal Binding of membrane-anchored macrophage colony-stimulating factor

  2011cites this paper
• New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases.

  2010cites this paper
• New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases Short title : Mechanisms of receptor tyrosine kinase activation

  2010cites this paper
• Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma

  2009cites this paper
• Comparison of nilotinib and imatinib inhibition of FMS receptor signaling, macrophage production and osteoclastogenesis

  2008cites this paper
• Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies.

  2008cites this paper
• Some effects of interface on fluid flow and heat transfer on micro-and nanoscale

  2007cites this paper
• Transcriptional regulation of c-fms gene expression

  2007cites this paper
• Expression of c-kit Receptor in Normal and Transformed Human Nonlymphoid Tissues1

  2006cites this paper
• Human Nonlymphoid Tissues Receptor in Normal and Transformed kit Expression of c-Updated Version

  2006cites this paper
• FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance

  2006cites this paper
• Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies.

  2006cites this paper
• Modulation of pl 45 c " kit Function in Cells of Patients with Acute Myeloblastic Leukemia 1

  2006influential citation
• Osteopetrotic Mouse Stroma with Thrombopoietin, c-kit Ligand, and flk-2 Ligand Supports Long-Term Mobilized CD34+ Hematopoiesis In Vitro

  2005cites this paper
• Colony-stimulating factor-1 induces rapid behavioural responses in the mouse macrophage cell line , BAC 1 . 2 F 5

  2005cites this paper
• Molecular cloning and expression analysis of a macrophage-colony stimulating factor receptor-like gene from rainbow trout, Oncorhynchus mykiss.

  2005cites this paper
• Planar heterogeneous structures for coherent emission of radiation.

  2005cites this paper
• Inhibition of Colony-Stimulating Factor-i Activity by Monoclonal Antibodies to the Human CSF-i Receptor

  2005cites this paper
• The role of colony-stimulating factors in acute leukemia

  2005cites this paper
• Cytokine receptors and signal transduction.

  2005cites this paper
• Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture

  2004influential citation
• Structural and functional studies of insulin receptors in human breast cancer

  2004cites this paper
• Features of thermal radiation of plane-parallel semiconductor wafers

  2004cites this paper
• The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update

  2004cites this paper
• Detection of Two Polymorphic Sites in the Human c-fms Gene: Allele Frequencies in Several Russian Populations

  2004cites this paper
• Purification and Identification of Protein-Tyrosine Kinase-binding Proteins Using Synthetic Phosphopeptides as Affinity Reagents *

  2004cites this paper
• Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].

  2003cites this paper
• Cloning and Expression of Murine Interleukin-1 Receptor Antagonist in Macrophages Stimulated by Colony-Stimulating Factor

  2003cites this paper
• Thermal radiation of plane-parallel semitransparent layers

  2003cites this paper
• The Human c-fpslfes Gene Product Expressed Ectopically in Rat Fibroblasts Is Nontransforming and Has Restrained Protein-Tyrosine Kinase Activity

  2003cites this paper
• Sherr cells and abrogates differentiation in response to granulocyte CSF responsiveness to interleukin-3-dependent 32 DC 13 mouse myeloid Human colony-stimulating factor 1 ( CSF-1 ) receptor confers CSF-1

  2003cites this paper
• Coherent emission of light by thermal sources

  2002cites this paper
• Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

  2002cites this paper
• Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression

  2002cites this paper
• Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

  2002cites this paper
• Colony-Stimulating Factor l-Induced STATl and STAT3 Activation Accompanied by Phosphorylation of Tyk2 in Macrophages and Tyk2 and JAKl in Fibroblasts

  2002cites this paper
• C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus

  2002cites this paper
• Class III receptor tyrosine kinases: role in leukaemogenesis

  2002cites this paper
• Production and function of a soluble c-Kit molecule / by Stuart Hamilton Read.

  2001cites this paper
• Acquisition of the monocyte/macrophage phenotype in human mesangial cells.

  2001cites this paper
• Transcriptional regulation of c-fms gene expression.

  2001cites this paper
• Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.

  2000cites this paper
• Substitution of two insulin receptor carboxy-terminal tyrosines with phenylalanine impairs the expression of MAP kinase phosphatase-1 (MKP-1) mRNA

  2000cites this paper
• Overexpression of Macrophage Colony-Stimulating Factor (CSF-I) and Its Receptor, c-fms, in Normal Ovarian Granulosa Cells Leads to Cell Proliferation and Tumorigenesis

  1999cites this paper
• The role of CSF-1 in normal and neoplastic breast physiology.

  1999cites this paper
• The Role of CSF-1 in Normal and Neoplastic Breast Physiology

  1999cites this paper
• STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation

  1999cites this paper
• Analysis of the modulation of transcriptional activity in myelopoiesis and leukemogenesis.

  1999cites this paper
• Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site.

  1999cites this paper
• Separation and Characterization of the Activated Pool of Colony-Stimulating Factor 1 Receptor Forming Distinct Multimeric Complexes with Signalling Molecules in Macrophages

  1999cites this paper
• Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42

  1999cites this paper
• Biological activities and clinical application of M-CSF.

  1998cites this paper
• Determinants for transformation induced by the Axl receptor tyrosine kinase

  1998cites this paper
• Stimulating cell proliferation through the pharmacologic activation of c-kit.

  1998cites this paper
• The Epstein-Barr Virus BARF1 Gene Encodes a Novel, Soluble Colony-Stimulating Factor-1 Receptor

  1998cites this paper
• Biological consequences of a point mutation at codon 969 of the FMS gene.

  1998cites this paper
• Multiple factors determine the selection of the ectodomain cleavage site of human cell surface macrophage colony-stimulating factor.

  1998cites this paper
• Hemopoietic growth factor receptor abnormalities in leukemia.

  1998cites this paper
• Activating mutations in cytokine receptors: implications for receptor function and role in disease.

  1997cites this paper
• Contribution of oncogenes and tumor suppressor genes to myeloid leukemia.

  1997cites this paper
• Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations

  1997cites this paper
• Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation

  1997cites this paper
• neu-mediated transformation . negatively and positively modulate Distinct tyrosine autophosphorylation sites

  1997cites this paper
• Transcription factors, normal myeloid development, and leukemia.

  1997cites this paper
• Macrophage colony-stimulating-factor (M-CSF or CSF-1) and its receptor: structure-function relationships.

  1997cites this paper
• Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor.

  1997cites this paper
• A novel 200 kDa plasma membrane glycoprotein with high basal tyrosine kinase activity in tumour cells.

  1997cites this paper
• Cytokine transcription in lymph nodes of cattle in different stages of bovine leukemia virus infection.

  1997cites this paper
• Absence of mutations in the RET gene in acute myeloid leukemia

  1997cites this paper
• Growth factor receptor tyrosine kinases

  1997cites this paper
• Effect of Dimerization on Signal Transduction and Biological Function of Oncogenic Ros, Insulin, and Insulin-like Growth Factor I Receptors*

  1997cites this paper
• The IGF-I receptor in cell growth, transformation and apoptosis.

  1997cites this paper
• Expression of Ki-67, tumor suppressor proteins, growth factor, and growth factor receptor in juvenile respiratory papillomatosis: Ki-67 and p53 as predictors of aggressive disease.

  1997cites this paper
• Protein tyrosine kinases and cancer.

  1997cites this paper
• Tyrosine Phosphorylation of the Juxtamembrane Domain of the v-Fms Oncogene Product Is Required for Its Association with a 55-kDa Protein*

  1996cites this paper
• Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.

  1996cites this paper
• Retroviral insertional mutagenesis as a strategy to identify cancer genes.

  1996cites this paper